TUMOR INFILTRATING LYMPHOCYTES
Clinical trials for TUMOR INFILTRATING LYMPHOCYTES explained in plain language.
Never miss a new study
Get alerted when new TUMOR INFILTRATING LYMPHOCYTES trials appear
Sign up with your email to follow new studies for TUMOR INFILTRATING LYMPHOCYTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells from your own tumor could fight cancer
Disease control CompletedThis early-stage study tested a treatment made from a patient's own tumor-fighting immune cells, called tumor-infiltrating lymphocytes (TILs). It included 43 adults with advanced solid tumors like melanoma, cervical cancer, and lung cancer. The goal was to find the safest dose an…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Immune cell attack: new hope for advanced melanoma patients
Disease control CompletedThis study tested a new treatment called GC101 TIL for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells, grown in a lab, to fight the cancer. The goal was to check safety and see if tumors shrink. 18 patient…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:11 UTC